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Abstract. Background: Current esti-
mates suggest 6,500 undocumented end-
stage renal disease (ESRD) patients in the 
United States are ineligible for scheduled 
hemodialysis and require emergent dialysis. 
In order to remain in compliance with Emer-
gency Medicaid, an academic health center 
altered its emergency dialysis criteria from 
those emphasizing interdialytic interval to a 
set emphasizing numerical thresholds. We re-
port the impact of this administrative change 
on the biochemical parameters, utilization, 
and adverse outcomes in an undocumented 
patient cohort. Methods: This retrospec-
tive case series examines 19 undocumented 
ESRD patients during a 6-month transition 
divided into three 2-month periods (P1, P2, 
P3). In P1, patients received emergent dialy-
sis based on interdialytic interval and clini-
cal judgment. In P2 (early transition) and P3 
(equilibrium), patients were dialyzed accord-
ing to strict numerical criteria coupled with 
clinical judgment. Results: Emergent crite-
ria-based dialysis (P2 and P3) was associated 
with increased potassium, blood urea nitro-
gen (BUN), and acidosis as compared to P1 
(p < 0.05). Overnight hospitalizations were 
more common in P2 and P3 (p < 0.05). More 
frequent adverse events were noted in P2 as 
compared to P1 and P3, with an odds ratio 
(OR) for the composite endpoint (intubation, 
bacteremia, myocardial infarction, intensive 
care unit admission) of 48 (5.9 – 391.2) and 
16.5 (2.5 – 108.6), respectively. Per-patient 
reimbursement-to-cost ratios increased dur-
ing criteria-based dialysis periods (P1: 1.49, 
P2: 2.3, P3: 2.49). Discussion: Strict adher-
ence to criteria-based dialysis models in-
creases biochemical abnormalities while 
improving Medicaid reimbursement for 
undocumented immigrants. Alternatives to 
emergent dialysis are required which mini-
mize cost, while maintaining dignity, safety, 
and quality of life.
Introduction
The current number of undocumented 
immigrants residing in the United States of 
America is estimated at 11 – 12 million [1]. 
Provision of healthcare for these individuals 
is an ongoing challenge. Healthcare costs for 
this population result in an annual burden of 
4.3 billion dollars in additional spending by 
city, state, and federal governments [2]. Un-
documented end-stage renal disease (ESRD) 
patients require indefinite hemodialysis 
(HD), posing a longitudinal financial burden 
to health systems nationwide [3].
Federal law explicitly denies healthcare-
related benefits to immigrants who are un-
documented or who have not met residency 
requirements, leaving such decisions to states 
that rely largely on emergency Medicaid 
( E-Medicaid) funds to cover these costs. Ad-
ditionally, the Affordable Health Care Act of 
2010 (ACA) does not support regular outpa-
tient dialysis care for undocumented immi-
grants [4, 5]. Further, planned reductions in 
E-Medicaid funding are predicted [6, 7], po-
tentially forcing individual hospital systems to 
absorb the heavy financial burden of treating 
undocumented ESRD patients [8]. This prac-
tice risks the solvency of the safety-net hospi-
tals these patients often depend upon and may 
increase costs for the general population. In 
Indiana, E-Medicaid reimbursement from the 
Centers of Medicare and Medicaid Services 
(CMS) is impacted by corporate emergency 
treatment criteria [9], such as the McKesson 
InterQual® criteria [10, 11]. These corporate 
criteria do not delineate explicit guidelines to 
provide emergent dialysis to ESRD patients. 
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Faced with this dilemma, some safety-net 
health centers have developed internal cri-
teria to help inform physicians whether un-
documented ESRD patients meet a threshold 
to receive emergency dialytic care [12, 13]. 
In these models, patients receive dialysis 
only after meeting the CMS definition of an 
emergency medical condition [14], frequently 
demonstrating life-threatening sequelae of 
their ESRD.
A well-organized, clearly-demarcated 
transition to a model based upon strict emer-
gent dialysis criteria occurred in an academic 
center’s safety-net hospital. This transition 
was not a clinical study; instead, the transi-
tion was administratively implemented by 
the health system in order to remain in regu-
latory compliance with Indiana Emergency 
Medicaid Services. Before and after the tran-
sition, up to 19 patients presented as needed 
to the emergency department (ED) for emer-
gency dialysis admissions because outpatient 
dialysis was unavailable for these patients in 
the health system. While all admissions met 
inpatient InterQual® criteria, the health sys-
tem emphasized different criteria to guide 
clinicians before and after the transition. 
Prior to the transition, patients were provid-
ed emergent dialysis based on clinical judg-
ment and an interdialytic interval equal to 
or exceeding 3 days. Most patients received 
intermittent dialysis twice weekly at consis-
tently spaced intervals, and were discharged 
following dialysis. On a predetermined date, 
patients were sharply transitioned to a care 
model in which clinicians were guided by 
numerical criteria developed by the health 
system. Criteria such as laboratory data and 
oxygen saturation levels were emphasized. 
Patients meeting criteria were admitted for 
dialysis. Patients were discharged without 
dialysis if they failed to meet criteria and 
clinicians agreed that an immediate threat to 
life was not present.
For 19 patients, we report the short-term 
medical and financial implications of this 
transition from criteria based on interdialytic 
interval (essentially twice weekly dialysis) to 
numerical thresholds.
Materials and methods
Study design
This is a retrospective case series of 19 
adult undocumented ESRD patients who re-
ceived emergent dialysis from an academic 
health system during a 6-month transition. 
The study was approved by the Institutional 
Review Board (IRB) of the university and 
safety-net hospital system.
Periods
The 6-month transition was divided into 
three distinct 2-month periods (P1, P2, and 
P3) listed in Table 1. Period 1 (P1) corre-
sponds to the 2 months immediately preced-
ing the transition wherein patients received 
intermittent dialysis twice weekly and were 
discharged following dialysis. On a prede-
termined date, all patients were sharply tran-
sitioned from P1 to a care model based on 
emergency dialysis criteria developed by the 
health system (Supplemental Document 1). 
Period 2 (P2) and period 3 (P3) represent the 
4 consecutive months following the transi-
tion. P2 corresponds to the “early transition,” 
immediately following the transition. P3 fol-
lowed P2 and represents an “equilibrium 
phase”. In clinical practice, no sharp demar-
cation existed between P2 and P3; however, 
Table 1. Description of periods.
Period Description of emergency dialysis criteria
P1 Pre-transition: Dialysis based on clinical judgment and an inter-dialytic interval equal to 
or exceeding 3 days. Admissions were initiated through the Emergency Department with 
same-day discharge.
P2 Early transition: Dialysis only when meeting numerical criteria (Supplemental Document 
1). Patients frequently required serial dialysis treatments after admission to improve 
electrolyte and volume status.
P3 Equilibrium: Dialysis for the same numerical criteria as P2, but fewer discharges without 
dialysis occurred in this period. Patients received serial dialysis treatments after 
admission.
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the authors divided these periods because 
considerable changes in the behavior of pa-
tients and practitioners were noted as they 
adjusted to the new criteria. For example, 
far fewer patients were discharged without 
dialysis in P3, perhaps related to patients’ 
better understanding of admission require-
ments and providers’ increased comfort in 
exercising clinical judgment to supersede the 
numerical criteria. At the rounding nephrolo-
gist’s discretion, patients in P2 and P3 often 
required serial dialysis with multiple-day 
admissions to improve clinical status, while 
reducing the dialysis disequilibrium risk.
Before the transition, protocols were es-
tablished for patient triage, admission, and 
discharge based on the new emergency di-
alysis criteria. Patients were given written 
information about the forthcoming changes, 
provided legal counsel to aid in changing 
immigration status, and offered travel as-
sistance to transition to a state or country 
with scheduled dialysis options. Counselors 
educated patients on uremic symptoms and 
nutrition. However, the transition was not a 
prospective study and this retrospective in-
vestigation was not a pre-specified compo-
nent of the transition. This study began as 
a fellow’s continuous quality improvement 
(CQI) project in response to the transition.
Patient selection
Patients were included in the study analy-
sis if all dialysis sessions in at least one pe-
riod (P1, P2, P3) were performed exclusively 
at the safety-net hospital (N = 19). Patients’ 
dialysis location for every treatment was ver-
ified using the Indiana Health Information 
Exchange, an internet system linking medi-
cal records for most health systems across 
the state of Indiana. Patients were excluded 
from statistical analyses for a given period 
if they did not receive dialysis in our health 
system or received dialysis in another health 
system during that period.
Data collection
Demographic, laboratory, resource utili-
zation, and outcome data were collected by 
chart review. Factors collected include: im-
migration status, dialysis vintage, dialysis 
access, dialysis session quantity, hours of 
dialysis received, interdialytic interval, num-
ber of ED visits, electrocardiograms (ECGs), 
chest radiographs, hospital nights crossing 
midnight, intensive care unit (ICU) days, av-
erage presenting blood pressure (BP), peak 
BP, average blood urea nitrogen (BUN), 
peak BUN, average potassium, peak potas-
sium, average calcium, phosphorus, pre-di-
alysis sodium, weight, albumin, parathyroid 
hormone (PTH), and hemoglobin. Peak re-
fers to the highest recorded value in a period, 
average is the mean of all values in a period. 
Adverse events from dialysis or lack of di-
alysis were recorded. Major adverse events 
included respiratory failure, bacteremia, ICU 
admission, and myocardial infarction (MI). 
Minor adverse events included blood trans-
fusions, dialysis disequilibrium, and inter-
ventional radiology (IR) procedures. No pa-
tients died during the study periods.
Charge, cost, and reimbursement 
data
Charge data were estimated according to 
both a basic and complex model. The models 
included hospital facility fees and location-
specific charge data from the American Med-
ical Association’s (AMA) Fair Health Con-
sumer cost lookup (Supplemental Table 1) 
(http://fairhealthconsumer.org/medicalcost-
lookup.php). The basic model included fa-
cility fees for ICU stays, nights hospitalized, 
ED visits, and dialysis sessions. The complex 
model included the basic model components 
as well as fees for chest radiographs, ECGs, 
laboratory testing, angioplasties, catheter ex-
changes, transfusions, and physician charges 
of the ED physicians, intensivists, hospital-
ists, and nephrologists. Costs and reimburse-
ments to the hospital system were obtained. 
Charges, costs, and reimbursements from P1, 
P2, and P3 were compared.
Statistical analysis
Statistical analysis was performed us-
ing SigmaStat 3.5 and GraphPad Prism 4.0. 
ANOVA and Kruskal-Wallis tests were used 
to compare normally and non-normally dis-
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tributed data, respectively. Data is presented 
as mean ± standard deviation or median 
(interquartile range). A multiple corrections 
testing penalty was applied with Holm-Sidak 
methodology. Thresholds of significance 
are p < 0.017 (first comparison), p < 0.025 
(second comparison), and p < 0.05 (third 
comparison). Categorical variables were 
compared with an odds ratio (OR) and 95% 
confidence interval (CI). p < 0.05 was con-
sidered significant.
Results
Baseline characteristics
Of the 19 undocumented ESRD patients, 
the mean age was 36.6 years, the mean dialy-
sis vintage was 20.2 months, and 74% had 
a functional arteriovenous fistula (Table 2, 
Supplemental Table 2). 18 patients received 
all of their dialysis sessions at the safety-net 
hospital during P1. Five of these left the co-
hort in early P2 and 1 returned in P3. The 
19th patient was not present all of P1, but was 
present during P2 and P3. Thus, there were 
18 patients in P1, 14 in P2, and 15 in P3. The 
main factors in attrition were immigration 
status change and transfer to another hospital 
system. The total number of ED encounters 
resulting in discharge without dialysis was 
assessed for the cohort. In P1, 1 encounter 
resulted in discharge from the ED without 
dialysis. In P2, 17 encounters resulted in dis-
charge without dialysis as compared to P3, 
when 3 visits failed to result in dialysis. ED 
presentations unrelated to ESRD symptoms 
were excluded.
Biochemical abnormalities and 
dialysis adequacy
Table 3 summarizes the significant bio-
chemical abnormalities across periods. The 
average of each patient’s peak serum potas-
sium level and mean potassium level varied 
significantly between periods (p = 0.003 for 
peak and p = 0.033 for mean). Patients re-
ceiving dialysis based on numerical criteria 
(P2 and P3) had higher serum potassium 
levels than P1. Potassium values for hemo-
lyzed blood samples were excluded. Mean 
serum bicarbonate levels varied across peri-
ods (p < 0.001), with lower levels during P2 
and P3 as compared to P1 (p < 0.001 for both 
comparisons). Both the average of each pa-
tient’s highest BUN level and the average of 
each patient’s mean BUN level varied across 
periods (p = 0.015 and 0.007, respectively). 
BUN levels were greater in P2 and P3 com-
pared to P1. No differences in potassium, 
bicarbonate, or BUN were noted between 
P2 and P3. Blood pressure, weight, sodium, 
hemoglobin, calcium, phosphorus, and PTH 
levels remained unchanged across periods.
The maximum interdialytic interval, 
quantity of dialysis sessions, and total hours 
of dialysis were determined. The median 
maximum interdialytic interval differed be-
tween periods (p < 0.001). The interval was 
shortest in P1 (4 days) and longer during 
P2 (8 days) and P3 (9 days), with p < 0.001 
for both comparisons. In contrast, the dialy-
sis session quantity did not change across 
periods (P1: 17.0 ± 4.1, P2: 16.9 ± 4.4, 
P3: 15.9 ± 4.7), as nephrologists often pro-
vided serial dialysis treatments during P2 
and P3. To prevent disequilibrium, some 
patients in P2 and P3 received abbreviated 
initial treatments upon admission. The me-
dian hours of dialysis varied between pe-
riods (p = 0.037). Total dialysis time was 
lower in P2 (58, 44 – 68 hours) compared to 
P1 (72, 68 – 72 hours), p = 0.006. Although 
the median of dialysis hours during P3 (57, 
39 – 76 hours) was similar to P2, the range 
was wider and not significantly different than 
either P1 or P2.
Table 2. Key demographics.
Patient characteristic Valuea
Age in years on May 1, 
2014, mean (range)
36.6 (22 – 50)
Dialysis vintage in months, 
mean (range)
20.25 (2 – 51.5)
Female gender, N (%) 6 (32)
Employed, N (%) 9 (47)
Married 11 (58)
US citizens 0
Number of children,  
mean (range)
2.3 (0 – 6)
Mexican, N (%) 14 (74)
Hypertensive, N (%) 17 (89)
Diabetic, N (%) 5 (26)
Arterio-venous fistula as 
access, N (%)
14 (74)
aMean (range) or number (percent) of total.
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Table 3. Mean or median statistics by period for all patients.
Clinical factor P1 P2 P3 p-valuea
P1 vs. P2
p-valuea
P1 vs. P3
p-valuea
P2 vs. P3
Average BP (mmHg) 152.6 ± 20.1 149.8 ± 22.6 156.2 ± 16.3 0.76 0.487 0.33
Peak BP (mmHg) 173.5 ± 25.4 163.7 ± 25.2 178.8 ± 19.3 0.13 0.472 0.025
Average BUNc (mg/dL) 86. 1 ± 1.6 111.6 ± 31.6 113.4 ± 29.8 0.006 0.003 0.86
Peak BUNc (mg/dL) 113.1 ± 27 137.5 ± 32.6 139.8 ± 27.0 0.02 0.007 0.58
Average potassiumc (mEq/L) 5.1 ± 0.4 5.7 ± 0.9 5.5 ± 0.8 < 0.001 0.002 0.35
Peak potassiumc (mEq/L) 5.9 ± 0.6 6.7 ± 1.2 6.4 ± 1.1 0.01 0.02 0.25
Average calcium (mg/dL) 8.3 ± 0.9 8.2 ± 0.8 8.7 ± 0.5 0.76 0.10 0.30
Average phosphorus (mg/dL) 6.6 ± 1.7 7.1 ± 1.9 6.7 ± 1.9 0.54 0.93 0.56
Average PTHb (pg/dL) 587 (395 – 760) 479 (362 – 810) 642 (372 – 935) 0.38 0.76 0.32
Average bicarbonatec (mEq/L) 21.4 ± 1.7 16.9 ± 3.7 17.6 ± 4.0 < 0.001 < 0.001 0.63
Average sodium (mEq/L) 136.3 ± 1.7 135.7 ± 2.1 136.0 ± 1.7 0.42 0.630 0.40
Average hemoglobin (g/dL) 9.8 ± 1.5 9.2 ± 1 9.1 ± 1.1 0.11 0.10 0.81
Peak weight (kg) 68.6 ± 13.9 76.6 ± 20.1 72.5 ± 18.5 0.55 0.59 0.19
Lowest weight (kg) 64.8 ± 15.5 67.5 ± 18.5 65.2 ± 18 0.11 0.065 0.071
Maximum inter dialytic 
intervalb,c (d)
4 (4 – 4) 8 (6 – 9.5) 9 (6 – 10.75) < 0.001 < 0.001 0.74
# of HD sessions 17 ± 4.1 16.9 ± 4.4 15.9 ± 4.7 0.93 0.49 0.59
# of hours of dialysisb,c 72 (68 – 72) 56 (44 – 65) 56 (45 – 73) 0.006 0.13 0.78
# of ED visitsb,c 17 (17 – 18) 8 (4 – 9) 8 (5 – 9) < 0.001 < 0.001 0.97
# of nights in hospitalb,c 0 (0 – 0) 13 (11.5 – 15) 11 (9 – 13) < 0.001 < 0.001 0.057
# of admissionsc 15.4 ± 5.2 5.9 ± 3.1 7.1 ± 3.0 < 0.001 < 0.001 0.27
# of days with ICU statusb,c 0 (0 – 0) 3 (0.5 – 6) 0 (0 – 0) 0.001 0.16 0.009
# of CXRc 0.6 ± 1.1 5.6 ± 2.5 5.3 ± 2.1 < 0.001 < 0.001 0.86
# of ECGc 0.9 ± 1.4 8.4 ± 2.7 8.8 ± 3.1 < 0.001 < 0.001 0.54
BP = blood pressure; BUN = blood urea nitrogen; PTH = parathyroid hormone; HD = hemodialysis; ICU = intensive care unit; CXR = chest 
X-ray; ECG = electrocardiogram. Mean ± SD or median (interquartile range) is presented for normally distributed and skewed data, respec-
tively. aUnadjusted p-values between comparisons are provided. When not noted, ANOVA was performed between groups. bIndicates a 
Kruskal-Wallis test was performed. cIndicates the ANOVA or Kruskal-Wallis study was significant with p < 0.05. Multiple corrections testing 
is applied with Holm-Sidak methodology. Thresholds of significance are p < 0.017 (first comparison), p < 0.025 (second comparison), and 
p < 0.05 (third comparison). Significant values are bolded. Conversion factors for urea nitrogen in mg/dL to mmol/L, ×0.357.
Table 4. Clinical endpoints.
P1 vs. P2 P1 vs. P3 P3 vs. P2
Adverse 
events
P1, N 
(%)
P2, N 
(%)
P3, N 
(%)
OR (95% CI) p OR (95% CI) p OR (95% CI) p
Major AE N = 18 N = 14 N = 15
Composite 
endpoint
2 (11) 12 (86) 4 (27) 48.0 (5.9 – 391.2) < 0.001 2.9 (0.5 – 18.7) 0.26 16.5 (2.5 – 108.6) 0.004
Composite, 
no ICU
1 (6) 6 (42) 4 (27) 12.8 (1.3 – 124.1) 0.029 6.2 (0.6 – 62.8) 0.12 2.06 (0.4 – 9.8) 0.36
Respirary 
failure
0 2 (14) 1 (7) 7.4 (0.3 – 167.6) 0.21 3.8 (0.1 – 101.1) 0.42 2.3 (0.2 – 29.0) 0.51
Bacteremia 1 (6) 3 (21) 1 (7) 4.6 (0.4 – 50.4) 0.21 1.2 (0.1 – 21.2) 0.89 3.8 (0.4 – 42.0) 0.27
NSTEMI 0 1 (7) 2 (13) 4.1 (0.2 – 108.9) 0.40 6.9 (0.3 – 154.6) 0.23 0.5 (0.0 – 6.22) 0.59
ICU 
admission
1 (6) 11 (79) 3 (20) 62.3 (5.7 – 678.2) < 0.001 4.3 (0.4 – 46.0) 0.23 14.7 (2.4 – 88.5) 0.003
Minor AE
Composite 
endpoint
4 (22) 8 (57) 5 (33) 4.7 (1.01 – 21.7) 0.05 1.8 (0.4 – 8.2) 0.48 0.4 (0.1 – 1.7) 0.20
Blood 
transfusion
3 (17) 5 (35) 2 (13) 2.8 (0.5 – 14.5) 0.23 0.8 (0.11 – 5.3) 0.79 3.6 (0.6 – 22.9) 0.17
Disequilibrium 1 (6) 1 (7) 1 (7) 1.3 (0.1 – 23.0) 0.85 1.2 (0.1 – 21.2) 0.89 1.1 (0.06 – 19.1) 0.96
IR procedure 
need
3 (17) 2 (14) 3 (20) 0.8 (0.1 – 5.8) 0.85 1.3 (0.2 – 7.4) 0.81 0.7 (0.1 – 4.7) 0.69
AE = adverse event; ICU = intensive care unit; NSTEMI = non-ST-elevation myocardial infarction; IR = interventional radiology.
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Adverse events
Major adverse events included respiratory 
failure, bacteremia, MI, and ICU admission. 
No patients died during the study. 26 major 
events were observed (Table 4). The majority 
occurred in P2 (65%), followed by P3 (27%) 
and P1 (8%). A composite endpoint including 
respiratory failure, bacteremia, non-ST-ele-
vation myocardial infarction (NSTEMI) and 
ICU admission occurred most frequently dur-
ing P2 (85.7%), followed by P3 (26.7%) and 
P1 (11%). The odds of meeting this composite 
endpoint in P2 as compared to P1 was 48.0 
(95% CI, 5.9 – 391.2). While the biochemical 
abnormalities of P2 and P3 closely mirrored 
each other, fewer adverse events were ob-
served in P3. The OR of meeting the compos-
ite endpoint in P2 compared to P3 was 16.5 
(2.5 – 108.6). No difference was observed 
between P1 and P3. A composite endpoint of 
respiratory failure, bacteremia, and NSTEMI 
(excluding ICU admission) was also exam-
ined. The OR for P2 compared to P1 was 12.8 
(95% CI, 1.3 – 124.4). No significant differ-
ence was noted for other comparisons.
21 minor adverse events occurred, in-
cluding blood transfusions, disequilibrium 
syndrome, and access related complications 
requiring catheter exchange, fistulogram, or 
angioplasty. Minor adverse events occurred 
most frequently in P2 (38%), followed by P1 
(30%) and P3 (28.57%). A composite OR of 
minor event occurrence between P1 and P2 
was marginally significant at 4.7 (95% CI, 
1.01 – 21.7; p = 0.05). Other OR compari-
sons were not significant.
Utilization
Healthcare utilization markers are sum-
marized in Table 3. The median number of 
nights hospitalized was different between 
periods (p < 0.001), as it increased from 0 
(0 – 0) in P1 to 13 (11 – 15) in P2 and 11 
(9 – 13) in P3 (p < 0.001 for P2 and P3 vs. 
P1). In P1, only 3 patients were hospitalized 
overnight. However, 1 was hospitalized for 
severe Clostridium difficile colitis between 
day 1 and day 60 of P1, because he was in-
eligible for nursing facility placement.
The number of days spent in the ICU 
varied across periods (p = 0.001). Median 
Table 5. Costs and reimbursements.
Economic factora P1 P2 P3
Per-patient charges (excludes physician charges) 79,885 77,140 74,687
Per-patient cost (excludes physician fees) 13,652 14,319 13,404
Per-patient reimbursement 20,309 32,959 33,329
Charge-to-reimbursement ratio 3.93 2.34 2.24
Reimbursement-to-cost ratio 1.49 2.3 2.49
aThese data were provided from the health system as composite data for the 
entire cohort. Individual patient data is unavailable. Data are presented as 
means per patient per 2-month period. Formal statistical analysis is precluded.
Figure 1. Charge estimates increase during P2. 
A: Participants receiving dialysis in P2 had signifi-
cantly greater charge estimates as compared to P1 
and P3 according to a basic model estimate of fa-
cility fees. Patients also had greater charge esti-
mates during P3 than P1. The median in P1 was 
$12,024 ($11,356 – 12,182), in P2 was $37,787 
($31,934 – 50,280), and in P3 was $26,516 
($20,255 – 30,267). B: According to the full model 
estimate including facility and physician fees, pa-
tients receiving dialysis during P2 had greater 
charge estimates than they did during P1 and P3. 
Changes observed between P1 and P3 were only 
significant if an outlier in P1 is excluded (#). The 
median P2 charge estimates were $54,148 
($46,771 – 68,220) as compared to P1 at $28,998 
($27,544 – 29,497). The P3 median charge esti-
mate was $41,840 ($31,387 – 47,742). Column 
lines represent median values. Estimates are per 
patient per 2-month period. *Statistically significant 
by Kruskal-Wallis after multiple testing correction.
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days of ICU status increased in P2 (3 days) 
compared to P1 (0 days) and P3 (0 days), 
p = 0.001 and 0.009, respectively. P3 did not 
differ significantly from P1. The number of 
ED visits and admissions both varied across 
periods (p < 0.001 for both), decreasing sig-
nificantly during P2 and P3 as compared to 
P1 (p < 0.001 for all comparisons to P1), as 
patients no longer presented to the ED twice 
weekly for intermittent dialysis. To measure 
radiology and ancillary service engagement, 
the number of chest radiographs and ECGs 
obtained per period were assessed and found 
to be different (p < 0.001 for both ANOVA 
tests). Chest radiograph and ECG acquisi-
tion increased in P2 and P3 compared to P1 
(p < 0.001 for both comparisons). P2 and P3 
did not differ in number of nights hospital-
ized, ED visits, admissions, chest radio-
graphs, or ECGs.
To determine the economic impact of 
these changes, charge estimates were assessed 
according to two models (Figure 1). In the 
basic and full models, charge estimates per 
patient varied between periods (p <  0.001). 
All basic model individual comparisons 
were statistically significant, with median P2 
charge estimates exceeding those of P1 and 
P3. P3 estimates also exceeded P1. In the full 
model which includes physician fees, P2 es-
timates were $54,148 per patient per period 
compared to $28,998 in P1 (p = 0.0015). In 
the full model, P3 did not differ from P1.
Actual aggregate charge, cost, and re-
imbursement data for the cohort were also 
obtained from the health system (Table 5), 
but do not include physician fees. Total 
per-patient charges and costs were similar 
across periods at ~ $75,000 and $14,000, 
respectively. In contrast, per patient reim-
bursements increased from $20,309 in P1 to 
$33,329 in P3. The reimbursement-to-cost 
ratio favored the emergency criteria systems 
over the provision of twice weekly dialysis 
(1.49 in P1, 2.3 in P2, 2.49 in P3). Analo-
gously, the charge-to-reimbursement ratio 
also favored emergency criteria-based dialy-
sis (3.93 in P1, 2.34 in P2, 2.24 in P3).
Discussion
In some US states, safety-net hospitals 
bear the burden of dialytic care for undocu-
mented immigrants because federal laws 
exclude these patients from government 
healthcare. Despite great interest from the 
Nephrology community [4, 8, 15], the ap-
proach to undocumented immigrant care 
remains controversial. This study analyzes a 
case series of undocumented ESRD patients 
exposed to two different dialytic care mod-
els. Neither model is ideal. The significance 
is in understanding the consequences of tran-
sitioning patients from intermittent dialysis 
to strict criteria-based emergent dialysis.
An unheralded success of the transition 
was the health system’s ability to facilitate 
legal immigration status for several patients 
prior to the start of P1 through careful case 
management and legal assistance. To ac-
complish this, the health system partnered 
with a community attorney specializing in 
immigration issues. She assisted 3 patients 
with securing outpatient dialysis chairs. One 
patient renewed an expired green card and 2 
other patients obtained asylum, allowing all 3 
to qualify for public funding. The attorney is 
currently working with 4 more patients seek-
ing legal citizen status: 1 related to her son 
being a citizen; 2 through the visa process; 
and 1 additional patient seeking asylum.
The most remarkable contrast lies between 
P1 and P2. In P2, where objective laboratory 
and oxygen saturation levels were principally 
considered, the patients’ biochemical ab-
normalities were of greater severity, adverse 
events were more frequent, and charge esti-
mates increased. These results parallel those 
of non-adherent chronic hemodialysis pa-
tients [16]. By the “equilibrium phase” of P3, 
patients and providers had adjusted to the new 
criteria. Five-fold fewer patients were dis-
charged without dialysis, and fewer adverse 
events occurred in P3 compared to P2.
The comparison between P1 and P3 high-
lights two methodological approaches to un-
documented dialytic care. Neither the quan-
tity of dialysis sessions nor the frequency of 
adverse events differed significantly between 
periods. The major difference between P1 and 
P3 was that treatments were intermittent in 
P1 and grouped in P3. Twice weekly dialysis 
in P1 was associated with more frequent ED 
presentations and admissions (by definition). 
However, dialysis in P3 was associated with 
longer interdialytic intervals and greater sever-
ity of biochemical abnormalities. The more ab-
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errant laboratory values of P3 were required for 
admission, but resulted in more frequent over-
night hospital stays for serial dialysis. Thus, 
the P1-to-P3 comparison is essentially that 
of even-spaced intermittent vs. bolus dialysis 
therapy. Although adverse events did not differ 
between P1 and P3 in this short study, the long-
term implications of hyperkalemia, uremia, 
and acidosis seen during P3 are associated with 
poorer outcomes in ESRD patients [17, 18, 
19, 20, 21, 22]. Furthermore, undocumented 
patients excluded from scheduled dialysis re-
peatedly experience debilitating symptoms and 
psychosocial distress [23].
The findings of our investigation mirror 
those of other centers. As in New York, our 
cohort was comprised of young immigrants 
of Hispanic ethnicity [24]. An academic 
center in Texas reported similar increases in 
utilization and cost, with lower Kt/V in im-
migrants provided hemodialysis emergently 
as opposed to immigrants receiving thrice 
weekly dialysis [25]. A report from Israel 
revealed similar biochemical abnormalities 
in 15 undocumented immigrants [26]. Our 
study is unique because it follows the same 
cohort of patients as it transitioned from con-
sistently spaced dialysis to emergent. It also 
updates previously reported financial impli-
cations [25] for the post-ACA era [27].
A prior investigation documented cost 
savings in transitioning to case manager-
based care models [12]. In the present inves-
tigation, the charge-to-reimbursement and 
reimbursement-to-cost ratios favored the P3 
care model despite increased hospitalization 
and utilization. One explanation is patients 
receiving intermittent twice weekly dialysis 
often do not meet thresholds for E-Medicaid 
reimbursement, even though a physician 
determined the need for inpatient admis-
sion. On a per-patient basis, there were no 
appreciable cost savings or losses during P3 
compared to P1. Our median charge estimate 
data revealed differences between periods in 
contrast to the aggregate mean charge data of 
the hospital system. Reasons for this discrep-
ancy may include outliers, small sample size, 
the inclusion of physician fees, and the fact 
that our charge estimates utilized usual and 
customary rates from the AMA (which may 
not reflect actual hospital system charges).
The main limitations of this study are its 
retrospective nature, small sample size, and 
high attrition rate. The sample size and high 
attrition rate limit conclusions, but the sam-
ple size was adequate to appreciate changes 
in factors with large effect sizes like adverse 
outcomes and charge estimates. The 2-month 
time periods were short, but selected to even-
ly match the length of the early transition 
phase of P2. Additional limitations include 
the use of surrogate dialysis adequacy mark-
ers since we could not calculate Kt/V and the 
high fistula rate which limits generalizability 
to other centers with higher catheter rates.
In summary, even carefully planned tran-
sitions to criteria-based emergency dialysis 
care models will require refinement. If health 
systems are required to change their undocu-
mented dialysis care model, they should avoid 
a P2 phase. Current CMS reimbursement pat-
terns are linked to InterQual® guidelines [9]. 
Subtle signs of volume overload and uremia 
are inadequately conveyed by guidelines. 
These guidelines, or any others devised to 
meet the CMS definition of an “emergency 
medical condition,” cannot substitute for 
clinical judgment to predict adverse events. 
In the short term, hospitals may expect im-
proved reimbursement with strict adherence 
to emergency criteria. However, consequenc-
es of under-dialysis preclude extrapolation of 
these financial data in the long term. Better 
alternatives to emergent dialysis are required 
to minimize societal cost, while maintaining 
dignity, safety, and quality of life in patients. 
Ultimately, these concerns may only be alle-
viated by comprehensive immigration reform 
and cost-effective CMS coverage for all dial-
ysis-dependent patients. A lack of data regard-
ing undocumented ESRD care has been cited 
as a reason for the slow pace of governmental 
reforms [15]. We hope the data presented in 
our study adds additional information to help 
advance these critical reforms.
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